thyssenkrupp nucera AG & Co KgaA
F:NCH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
thyssenkrupp nucera AG & Co KgaA
F:NCH2
|
DE |
|
RT Minerals Corp
XTSX:RTM
|
CA |
|
Quince Therapeutics Inc
NASDAQ:QNCX
|
US |
|
Ariana Resources PLC
LSE:AAU
|
UK |
|
Vusiongroup SA
PAR:VU
|
FR |
|
N
|
Ninety One PLC
LSE:N91
|
UK |
|
M
|
MPX Logistics International Tbk PT
IDX:MPXL
|
ID |
Wall St Price Targets
NCH2 Price Targets Summary
thyssenkrupp nucera AG & Co KgaA
According to Wall Street analysts, the average 1-year price target for NCH2 is 11.19 EUR with a low forecast of 8.32 EUR and a high forecast of 16.76 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NCH2's stock price target?
Price Target
11.19
EUR
According to Wall Street analysts, the average 1-year price target for NCH2 is 11.19 EUR with a low forecast of 8.32 EUR and a high forecast of 16.76 EUR.
What is the Revenue forecast for thyssenkrupp nucera AG & Co KgaA?
Projected CAGR
-3%
Over the last 4 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is -3%.
What is the Net Income forecast for thyssenkrupp nucera AG & Co KgaA?
Projected CAGR
93%
Over the last 4 years, the compound annual growth rate for Net Income has been -32%. The projected CAGR for the next 3 years is 93%.
